Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:CVRX
NasdaqGS:CVRXMedical Equipment

CVRx (CVRX) Q3 Loss Near US$12.9 Million Reinforces Profitability Concerns Despite Growth Narratives

Setting the scene on CVRx's latest results CVRx (CVRX) has reported third quarter FY 2025 revenue of US$14.7 million with a basic EPS loss of US$0.49, alongside trailing twelve month revenue of US$56.0 million and a basic EPS loss of US$2.02, giving investors a clear view of a company still in investment mode. The company has seen quarterly revenue move from US$11.8 million in Q2 2024 to US$14.7 million in Q3 2025. Quarterly basic EPS losses have ranged between US$0.43 and US$0.65 over the...
NasdaqGM:SITM
NasdaqGM:SITMSemiconductor

SiTime Nears US$3b Renesas Deal That Could Redefine Growth Story

SiTime, ticker NasdaqGM:SITM, is reportedly nearing a major acquisition of Renesas Electronics' timing unit. The deal, if completed, would be the largest acquisition in SiTime's history. The move could reshape the competitive dynamics in the timing solutions space and expand SiTime's product reach. SiTime enters this potential transaction with strong recent share price momentum, with the stock at $420.23 and up 136.9% over the past year and 239.4% over the past 5 years. In the shorter term,...
NasdaqGS:SBUX
NasdaqGS:SBUXHospitality

Starbucks Fashion Week Push Tests Brand Relevance And Investor Payoff

Starbucks (NasdaqGS:SBUX) is partnering with fashion designers for Fashion Week to refresh its brand and reach younger consumers. The company is serving as an exclusive coffee partner at Fashion Week events, integrating its products into runway shows and pop up experiences. The collaboration includes limited time drink designs and branded activations targeted at social media focused audiences. For you as an investor, this Fashion Week push sits at the intersection of branding and...
NYSE:LMND
NYSE:LMNDInsurance

Lemonade’s AI Fueled Growth Confronts Ongoing Losses And Return Concerns

Lemonade (NYSE:LMND) reports that its customer base nearly tripled over the past five years, supported by AI tools and a fully digital insurance platform. The company has pushed into new products and markets using its proprietary technology to automate underwriting, pricing, and claims handling. Despite this expansion, Lemonade remains unprofitable with declining earnings per share and a negative return on equity that raises questions about its business model. For you as an investor,...
NYSE:NEU
NYSE:NEUChemicals

Has The Recent Share Price Slide Opened An Opportunity In NewMarket (NEU)?

Are you wondering if NewMarket's current share price reflects its real worth, or if the recent moves have opened up a mispricing you could potentially take advantage of? The stock last closed at US$592.80, after an 18.1% decline over the past week and a 16.4% decline over the past month. This comes even though the 1 year, 3 year and 5 year returns sit at 11.1%, 82.1% and 67.3% respectively. Recent attention on NewMarket has focused on its role in the materials sector and how investors are...
NYSE:BBT
NYSE:BBTBanks

Assessing Beacon Financial (BBT) Valuation After Recent Share Price Momentum And Merger Synergy Hopes

Beacon Financial (BBT) has caught investor attention after recent share price moves, with the stock showing a mix of short term pullback and stronger performance over the past month and past 3 months. See our latest analysis for Beacon Financial. With the share price at $30.68, Beacon Financial’s recent pullback over the last week sits against a much stronger backdrop, with a 30 day share price return of 14.52% and a 90 day share price return of 21.36%, pointing to building momentum even...
NasdaqGS:TRIP
NasdaqGS:TRIPInteractive Media and Services

Is Tripadvisor (TRIP) Pricing Look Anomaly After Prolonged Share Price Weakness

If you are wondering whether Tripadvisor's current share price reflects its true worth, or if the market has swung too far in one direction, this article is for you. The stock has been under pressure recently, with returns of a 24.7% decline over 7 days, a 30.3% decline over 30 days, a 34.4% decline year to date, a 46.0% decline over 1 year and 56.1% and 75.9% declines over 3 and 5 years respectively from a last close of US$9.61. These moves have kept Tripadvisor in focus as investors...
NasdaqGS:RIVN
NasdaqGS:RIVNAuto

Rivian Automotive (RIVN) Earnings Highlight Persistent US$811 Million Q4 Loss Challenging Bullish Narratives

Rivian Automotive (RIVN) just closed out FY 2025 with fourth quarter revenue of US$1.3 billion, a basic EPS loss of US$0.66, and net income loss of US$811 million, setting the tone for how investors will read the full year. Over the past six quarters, revenue has moved between US$874 million in Q3 2024 and US$1.7 billion in Q4 2024, while quarterly basic EPS has ranged from a loss of US$0.48 in Q1 2025 to a loss of US$1.08 in Q3 2024. This highlights a business that is scaling the top line...
NasdaqGS:SKWD
NasdaqGS:SKWDInsurance

Did Skyward’s New Power Generation Coverage Just Reframe Skyward Specialty Insurance Group's (SKWD) Investment Narrative?

In early February 2026, Skyward Specialty Insurance Group, Inc. launched a specialized Power Generation insurance solution for small to mid-sized U.S. power entities, targeting assets across their lifecycle and addressing coverage gaps for power plants, utilities, microgrids, battery storage, and alternative energy facilities. This move broadens Skyward Specialty’s energy offering beyond its existing Renewable Energy program, potentially deepening its role in insuring complex, evolving power...
SWX:SCHN
SWX:SCHNMachinery

Schindler Holding (SWX:SCHN) Margin Improvement Tests Premium Valuation Narratives

Schindler Holding (SWX:SCHN) has wrapped up FY 2025 with fourth quarter revenue of CHF 2.8b and basic EPS of CHF 2.44, alongside trailing twelve month revenue of CHF 10.9b and EPS of CHF 9.48 that sit against earnings growth of 12.9% over the past year. The company has seen quarterly revenue move from CHF 2.9b in Q4 2024 to CHF 2.8b in Q4 2025, while basic EPS shifted from CHF 1.81 to CHF 2.44 over the same period, setting up a story where investors will be weighing solid earnings progress...
NYSE:FDS
NYSE:FDSCapital Markets

FactSet’s AI Push And European Deal Versus Depressed Share Price Estimates

FactSet Research Systems (NYSE:FDS) announced an expanded partnership to bring Kepler Cheuvreux’s Aftermarket Research onto the FactSet platform, increasing its European research coverage. The company also introduced a beta release of AI Doc Ingest for Cobalt, a tool designed to automate private capital document ingestion and data extraction. These developments highlight FactSet’s focus on proprietary AI tools and broader content partnerships across public and private markets. FactSet is...
ENXTPA:AIR
ENXTPA:AIRAerospace & Defense

Should Air Canada’s A350-1000 Order Shape Airbus (ENXTPA:AIR) Investors’ View on Long-Haul Backlog Quality?

In early February 2026, Air Canada disclosed a firm order for eight Airbus A350-1000 widebody aircraft, with rights to purchase eight more, to modernize its long-haul fleet and support future ultra-long-haul routes from Canada to markets such as India, Southeast Asia, and Australia. This win further entrenches the A350 family as a core platform for global network carriers, reinforcing Airbus’s position in fuel-efficient, long-range widebodies at a time when airlines are prioritizing lower...
TSX:BIR
TSX:BIROil and Gas

How Record 2025 Output, Lower Costs and New Board Role At Birchcliff Energy (TSX:BIR) Has Changed Its Investment Story

Birchcliff Energy Ltd. recently reported unaudited fourth-quarter and full-year 2025 results, delivering record average production of 80,086 boe/d alongside lower per-unit operating costs and detailing a portfolio weighted to natural gas, condensate and NGLs. The company also highlighted significant remaining reserves and largely unbooked Elmworth potential while adding President and CEO Chris Carlsen to its board, signalling a tighter alignment between operational leadership and corporate...
OM:VERT B
OM:VERT BSoftware

Vertiseit (OM:VERT B) Margin Compression Challenges Bullish Growth Narratives After FY 2025 Results

Vertiseit (OM:VERT B) has wrapped up FY 2025 with fourth quarter revenue of SEK186.8 million, basic EPS of SEK0.22 and net income of SEK6.7 million, giving investors a fresh read on both growth and profitability. Over recent periods, the company has seen quarterly revenue move between SEK150.7 million and SEK202.8 million, while basic EPS has ranged from a loss of SEK0.56 to a profit of SEK0.48, setting a wide but clear context for how FY 2025 played out on the income line. With trailing 12...
NasdaqGS:MLKN
NasdaqGS:MLKNCommercial Services

Is It Too Late To Consider MillerKnoll (MLKN) After Recent Share Price Rebound

If you are wondering whether MillerKnoll at around US$21.78 still offers value or if the easy gains are gone, this article will explain what the current price reflects in more detail. The stock has shown a mixed pattern, with a 13.2% return over the last 30 days and 19.3% year to date, but a 3.4% decline over the past week and a 32.0% decline over five years that some investors may still have in mind. Recent coverage has focused on how MillerKnoll fits into the commercial services and office...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Assessing Travere Therapeutics (TVTX) Valuation After Recent Share Price Weakness And FILSPARI Growth Hopes

Travere Therapeutics overview Travere Therapeutics (TVTX) has drawn investor attention after recent trading, with the share price at $27.82 and mixed performance across different periods, including a negative move over the past 3 months but a positive 1 year total return. See our latest analysis for Travere Therapeutics. The recent 1 day share price return of negative 9.09% extends a weaker short term trend, with the 90 day share price return at negative 19.36%, even though the 1 year total...
TSX:RUS
TSX:RUSTrade Distributors

A Look At Russel Metals (TSX:RUS) Valuation As Models Give Mixed Signals On Fair Value

Russel Metals share performance snapshot Russel Metals (TSX:RUS) has seen mixed share performance recently, with a small one-day gain alongside a seven-day decline, while returns over the past month and past three months move in different directions. See our latest analysis for Russel Metals. At around CA$47.12, Russel Metals’ short term share price return has cooled after a stronger 90 day run of 18.39%. Its 1 year total shareholder return of 14.60% and 5 year total shareholder return of...
ENXTAM:MICC
ENXTAM:MICCFood

Magnum Ice Cream (ENXTAM:MICC) Margin Compression Challenges Bullish Earnings Growth Narratives

Magnum Ice Cream (ENXTAM:MICC) has wrapped up FY 2025 with second half revenue of €3.4b and a net loss of €161m, following first half revenue of €4.5b and net income of €454m, alongside prior second half 2024 revenue of €3.6b and net income of €127m. Over the last 12 months, total revenue has sat in a tight band between €7.6b and €8.1b, while net income has ranged from €293m to €581m. This gives investors a clear view of how earnings power and profitability have shifted through the year. With...
NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

A Closer Look At Baidu (NasdaqGS:BIDU) Valuation After Recent Share Price Weakness

Why Baidu (NasdaqGS:BIDU) is on investors’ radar today Baidu (NasdaqGS:BIDU) has drawn fresh attention after recent share price moves, with the stock showing a 1 day return of a 1% decline and a past month return of a 9% decline. See our latest analysis for Baidu. At a share price of US$137.01, Baidu’s recent 7 day share price return of a 6.11% decline and 30 day share price return of an 8.96% decline contrast with its 18.11% 90 day share price gain and 40.55% 1 year total shareholder return...
NYSE:RXO
NYSE:RXOTransportation

Has RXO’s (RXO) Costly Refi and Downgrade Quietly Tilted Its Earnings Risk Profile?

RXO, Inc. recently completed a US$400 million offering of 6.375% senior unsecured notes due 2031, planning to use the proceeds to redeem its existing 7.500% notes due 2027, cover related costs, and fund general corporate purposes. This refinancing push came alongside weaker fourth-quarter results, a goodwill impairment, and a Moody’s downgrade to Ba1, all highlighting pressure on RXO’s earnings profile and balance sheet quality. We’ll now examine how RXO’s weaker quarter and loss of...